Abstract
Migraine is a primary headache disorder associated with a high socioeconomic burden. The first step in effective migraine management,
following confirmation of the diagnosis, is patient education: the condition is carefully explained, to ensure that it is properly understood,
and realistic expectations are set. The choice of acute treatment has changed over time as the available therapeutic options have increased.
Abortive migraine therapy can be either specific (ergot derivatives and triptans) or non-specific (analgesics and non-steroidal anti-inflammatory
drugs). Even though acute symptomatic therapy can be optimised, migraine remains a chronic and potentially progressive condition
Lingua originale | English |
---|---|
pagine (da-a) | 265-269 |
Numero di pagine | 5 |
Rivista | European Neurological Review |
Volume | 6 |
Stato di pubblicazione | Pubblicato - 2011 |
Keywords
- ACUTE TREATMENT
- MIGRAINE
- TRIPTANS
- non-steroidal anti-inflammatory drugs